News from neurocrine biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 29, 2014, 10:00 ET

Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its second quarter 2014 financial results...

Jun 11, 2014, 07:00 ET

Neurocrine Biosciences Presenting NBI-98854 Scientific Abstracts And Posters At The International Parkinson And Movement Disorder Society's 18th Annual Congress

 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that on June 11, 2014, two scientific posters associated with its study of...

May 29, 2014, 13:00 ET

Neurocrine Biosciences To Present At The Jefferies 2014 Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

May 08, 2014, 13:00 ET

Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

May 01, 2014, 13:00 ET

Neurocrine Biosciences to Present at Deutsche Bank's 39th Annual Health Care Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Apr 30, 2014, 16:01 ET

Neurocrine Biosciences Reports First Quarter 2014 Results

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended March 31, 2014.  For the first quarter...

Apr 25, 2014, 15:30 ET

Neurocrine Biosciences Announces Conference Call And Webcast To Report First Quarter 2014 Financial Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its first quarter 2014 financial results after the Nasdaq...

Mar 04, 2014, 14:00 ET

Neurocrine Biosciences To Present At The 26th Annual Roth Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Feb 27, 2014, 19:00 ET

Neurocrine Biosciences To Present At The Cowen And Company 34th Annual Health Care Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Feb 26, 2014, 21:12 ET

Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the pricing of an underwritten public offering of 8,000,000 shares of its...

Feb 25, 2014, 16:00 ET

Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it is offering to sell 7,000,000 shares of its common stock in an underwritten...

Feb 25, 2014, 07:30 ET

Neurocrine Biosciences Announces NBI-98854 Scientific Presentations at the International Parkinson and Movement Disorder Society's 18th Annual Congress

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that two NBI-98854 scientific abstracts have been accepted for the scientific program at...

Feb 07, 2014, 10:00 ET

Neurocrine Biosciences To Present At The Leerink Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Tim Coughlin, Chief Financial Officer of Neurocrine Biosciences, will be...

Feb 06, 2014, 16:01 ET

Neurocrine Biosciences Reports Fourth Quarter And Year End 2013 Results

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter and year ended December 31, 2013. For the...

Feb 04, 2014, 09:20 ET

Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End 2013 Financial Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its fourth quarter and year-end 2013 financial results...

Jan 09, 2014, 16:31 ET

Neurocrine Announces 12-Week Safety Results From Initial Phase IIB Study Of VMAT2 Inhibitor NBI-98854

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-98854, a small molecule VMAT2 inhibitor, in development for tardive...

Jan 06, 2014, 16:01 ET

Neurocrine Announces Positive Results of VMAT2 Inhibitor NBI-98854 in Kinect 2 Study

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-98854, a small molecule VMAT2 inhibitor, showed a statistically...

Dec 04, 2013, 13:00 ET

Neurocrine Biosciences To Present At Oppenheimer's 24th Annual Healthcare Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Nov 26, 2013, 13:00 ET

Neurocrine Biosciences To Present At Deutsche Bank 2013 Biofest And The 25th Annual Piper Jaffray Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

Oct 29, 2013, 16:01 ET

Neurocrine Biosciences Reports Third Quarter 2013 Results

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended September 30, 2013. For the third...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge